These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29464180)

  • 1.
    Yang L; Lin W; Nugent CA; Hao S; Song H; Liu T; Zheng P
    Int J Genomics; 2017; 2017():2790864. PubMed ID: 29464180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages.
    Cao L; Xu E; Zheng R; Zhangchen Z; Zhong R; Huang F; Ye J; Sun H; Fan Y; Xie S; Chen Y; Xu Y; Cao J; Cao W; Liu C
    Chin Med; 2022 Jan; 17(1):7. PubMed ID: 34983596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
    Dang Y; Hao S; Zhou W; Zhang L; Ji G
    BMC Complement Altern Med; 2019 Jan; 19(1):8. PubMed ID: 30616587
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhu M; Hao S; Liu T; Yang L; Zheng P; Zhang L; Ji G
    Oncotarget; 2017 Oct; 8(47):82621-82631. PubMed ID: 29137289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine.
    Dang Y; Xu J; Yang Y; Li C; Zhang Q; Zhou W; Zhang L; Ji G
    Biomed Pharmacother; 2020 Jul; 127():109976. PubMed ID: 32559839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach.
    Dai L; Xu J; Liu B; Dang Y; Wang R; Zhuang L; Li D; Jiao L; Wang J; Zhang L; Zhong LLD; Zhou W; Ji G
    Front Med; 2022 Oct; 16(5):745-759. PubMed ID: 35471471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese medicine formula lingguizhugan decoction improves Beta-oxidation and metabolism of Fatty Acid in high-fat-diet-induced rat model of Fatty liver disease.
    Liu T; Yang LL; Zou L; Li DF; Wen HZ; Zheng PY; Xing LJ; Song HY; Tang XD; Ji G
    Evid Based Complement Alternat Med; 2013; 2013():429738. PubMed ID: 23762134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling.
    Li X; Xu G; Wei S; Zhang B; Yao H; Chen Y; Liu W; Wang B; Zhao J; Gao Y
    BMC Complement Altern Med; 2019 Dec; 19(1):360. PubMed ID: 31829159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
    Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
    Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
    Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
    J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway.
    Yang J; Tao D; Ma W; Liu S; Liao Y; Shu L; Zhang S; Li C; Du N; Shi Z
    Evid Based Complement Alternat Med; 2020; 2020():6363748. PubMed ID: 33178320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
    Chun HJ; Shim YJ; Kwon YH
    J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and therapeutic mechanism of Yinzhihuang on steatohepatitis in rats induced by a high-fat, high-cholesterol diet.
    Zeng J; Liu XL; Xin FZ; Zhao ZH; Shao YL; Yang RX; Pan Q; Fan JG
    J Dig Dis; 2020 Mar; 21(3):179-188. PubMed ID: 31950587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats.
    Ning Y; Gong Y; Zheng T; Xie Y; Yuan S; Ding W
    Diabetes Metab Syndr Obes; 2022; 15():2427-2442. PubMed ID: 35971521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y; Chen L; Wang H; Narisi B; Chen B
    J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.